| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.31T | 1.30T | 1.26T | 1.24T | 1.16T |
| Gross Profit | 424.18B | 404.13B | 376.00B | 362.30B | 341.83B |
| EBITDA | 164.60B | 161.71B | 147.07B | 142.10B | 137.58B |
| Net Income | 75.17B | 81.92B | 77.93B | 69.26B | 37.07B |
Balance Sheet | |||||
| Total Assets | 1.43T | 1.33T | 1.32T | 1.23T | 1.20T |
| Cash, Cash Equivalents and Short-Term Investments | 97.19B | 142.59B | 138.57B | 101.08B | 144.53B |
| Total Debt | 144.78B | 110.83B | 120.72B | 120.46B | 122.56B |
| Total Liabilities | 546.80B | 495.42B | 502.31B | 495.60B | 496.17B |
| Stockholders Equity | 851.19B | 807.35B | 792.33B | 705.03B | 674.64B |
Cash Flow | |||||
| Free Cash Flow | -22.48B | 61.13B | 60.56B | 26.87B | 68.03B |
| Operating Cash Flow | 78.30B | 119.23B | 106.63B | 71.54B | 105.02B |
| Investing Cash Flow | -68.70B | -61.51B | -18.52B | -59.43B | 2.69B |
| Financing Cash Flow | -46.95B | -61.20B | -53.02B | -62.91B | -54.73B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥617.79B | 17.43 | 13.63% | 1.95% | -1.79% | 1.03% | |
73 Outperform | ¥177.28B | 10.76 | ― | 2.66% | -4.58% | 51.25% | |
71 Outperform | ¥224.76B | 18.16 | ― | 3.90% | 1.23% | 11.14% | |
69 Neutral | ¥184.13B | 7.84 | 8.27% | 2.68% | 3.42% | 13.11% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥915.68B | 9.71 | 7.53% | 3.13% | 0.89% | -6.71% | |
46 Neutral | ¥307.83B | -3.58 | -20.43% | 3.72% | -13.16% | -410.43% |